The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
4CAST: A phase 1b dose exploration, open-label, single-center study evaluating the safety of INO-464 in combination with chemotherapy in patients with metastatic breast cancer.
 
Rachel Fitz-Gerald Dear
No Relationships to Disclose
 
Jia (Jenny) Liu
Honoraria - MSD; Specialised Therapeutics
Consulting or Advisory Role - Greywolf Therapeutics (Inst); Starpharma (Inst)
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - ImmVirX; MSD; Starpharma
 
Rasha Cosman
No Relationships to Disclose
 
Natalie Walsh
No Relationships to Disclose
 
Mariz Selga
No Relationships to Disclose
 
Beatriz Perez San Juan
No Relationships to Disclose
 
Carley Purcell
No Relationships to Disclose
 
Christine Louise Chaffer
Employment - Kembi Therapeutics Pty LtD
Stock and Other Ownership Interests - Kembi Therapeutics Pty Ltd
Patents, Royalties, Other Intellectual Property - Kembi Therapeutics Pty Ltd
Travel, Accommodations, Expenses - 10x Genomics